Literature DB >> 20639681

Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia.

M Moll1, R Goelz, T Naegele, M Wilke, C F Poets.   

Abstract

Two extremely low birth weight (ELBW) infants developed characteristic signs of kernicterus at 4 and 8 months corrected age despite only moderate neonatal hyperbilirubinemia (peak serum bilirubin <10 g/dl) and phototherapy being applied according to current guidelines. Both girls were from twin pregnancies and had fetal complications (donor in a twin-twin transfusion syndrome and acardius-acranius malformation in the second twin, respectively), connatal anemia (initial hematocrit 30%), and mild acidosis after birth. They had been neurologically normal at discharge except for abnormal otoacustic emissions (OAE). At the time kernicterus was diagnosed, both infants were nearly deaf, showed severe psychomotor retardation with dystonic features and had marked bilateral hyperintensities in the globus pallidum on MRI. Based on these and similar cases from the literature, we question whether current phototherapy guidelines are appropriate for high-risk ELBW infants. Lower thresholds may be preferable, at least if additional risk factors, such as anemia, are present.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20639681     DOI: 10.1159/000302719

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  9 in total

Review 1.  The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?

Authors:  Tao Xiong; Yi Qu; Stephanie Cambier; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-04-01       Impact factor: 3.183

2.  Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.

Authors:  Abd El-Rahman El-Mashad; Heba El-Mahdy; Doaa El Amrousy; Marwa Elgendy
Journal:  Eur J Pediatr       Date:  2016-12-21       Impact factor: 3.183

Review 3.  Audiologic impairment associated with bilirubin-induced neurologic damage.

Authors:  Cristen Olds; John S Oghalai
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-07       Impact factor: 3.926

Review 4.  High unbound bilirubin for age: a neurotoxin with major effects on the developing brain.

Authors:  Rowena Cayabyab; Rangasamy Ramanathan
Journal:  Pediatr Res       Date:  2018-12-05       Impact factor: 3.756

5.  Hyperbilirubinemia and neurodevelopmental outcome of very low birthweight infants: results from the LIFT cohort.

Authors:  Gaël Mazeiras; Jean-Christophe Rozé; Pierre-Yves Ancel; Gaëlle Caillaux; Anne Frondas-Chauty; Sophie Denizot; Cyril Flamant
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

6.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

7.  The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrial.

Authors:  Christian V Hulzebos; Peter H Dijk; Deirdre E van Imhoff; Arend F Bos; Enrico Lopriore; Martin Offringa; Selma A J Ruiter; Koen N J A van Braeckel; Paul F M Krabbe; Elise H Quik; Letty van Toledo-Eppinga; Debbie H G M Nuytemans; Aleid G van Wassenaer-Leemhuis; Manon J N Benders; Karen K M Korbeeck-van Hof; Richard A van Lingen; Liesbeth J M Groot Jebbink; Djien Liem; Petri Mansvelt; Jan Buijs; Paul Govaert; Ineke van Vliet; Twan L M Mulder; Cecile Wolfs; Willem P F Fetter; Celeste Laarman
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

Review 8.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

9.  Evaluation of treatment thresholds for unconjugated hyperbilirubinemia in preterm infants: effects on serum bilirubin and on hearing loss?

Authors:  Christian V Hulzebos; Paula van Dommelen; Paul H Verkerk; Peter H Dijk; Henrica L M Van Straaten
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.